Oncology
Cancer clinical trials
Studies of cancers and tumors of every type and site, from prevention to treatment. We’re tracking 20,306 recruiting studies in this area right now.
By phase
- Not applicable9,599
- Phase 24,428
- Phase 12,678
- Phase 1/Phase 21,650
- Phase 31,399
- Phase 2/Phase 3286
- Phase 4266
Top conditions
- Breast Cancer1,206
- Prostate Cancer645
- Cancer638
- Colorectal Cancer481
- Lung Cancer422
- Ovarian Cancer342
- Multiple Myeloma330
- Pancreatic Cancer288
- Gastric Cancer285
- Acute Myeloid Leukemia283
- Hepatocellular Carcinoma257
- Solid Tumor245
- Advanced Solid Tumor232
- Head and Neck Cancer228
- Cervical Cancer226
- Endometrial Cancer215
- Advanced Solid Tumors206
- Esophageal Cancer191
Leading sponsors
- M.D. Anderson Cancer Center454
- Fudan University305
- National Cancer Institute (NCI)294
- Memorial Sloan Kettering Cancer Center291
- Sun Yat-sen University274
- Mayo Clinic238
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences145
- City of Hope Medical Center145
- AstraZeneca133
- Ruijin Hospital128
Where studies are running
- California1,397
- Texas631
- Arizona508
- Florida436
- Alabama429
- New York406
- Massachusetts339
- Maryland331
- New Jersey275
- Pennsylvania236
Recruiting studies20,306 total
- NCT06424301RecruitingEarly Phase 1
Targeted gene therapy for hard-to-treat retinoblastoma
This trial tests an experimental drug that targets a specific gene (NUDT21) to treat retinoblastoma that has not responded to standard treatments. It is for children who have active tumor in only one eye and whose only other option is to remove the eye, but who want to try to save the eye instead.
ShanghaiAges 6 months+ - NCT05785754RecruitingPhase 1
Early drug study for advanced solid tumors
This Phase 1 study tests DCSZ11 in people with advanced or metastatic solid tumors (cancers that can’t be removed or have spread) given alone or with other treatments. It’s designed to find a safe dose and to see whether the treatment shows signs of shrinking cancer.
Birmingham, AlabamaAges 18 years+ - NCT06308029Recruiting
E-health pain self-management for breast cancer survivors
This trial tests an online program to help people manage lasting pain after breast cancer treatment. It's designed for those whose pain still gets in the way of daily life, even after finishing primary treatment.
AntwerpAges 18 years+ - NCT06869512Recruiting
Cancer survivors wellness program in Oklahoma
This trial tests a wellness program for cancer survivors in Oklahoma who have finished active treatment. It may help you regain strength and well-being in a group setting.
Tulsa, OklahomaAges 18 years+ - NCT06732505RecruitingPhase 1
Ac-225 DOTATATE for SSTR+ GEP-NETs: A Safety Study
This trial tests a new drug, Ac-225 DOTATATE, in people with a type of gut or pancreas tumor (GEP-NET) that has specific proteins (SSTR) on its surface. The goal is to see if it is safe and helps shrink or slow the tumor.
Beijing, Beijing MunicipalityAges 18–80 - NCT06839001RecruitingPhase 3
Freezing small breast tumors instead of surgery trial
This study tests if freezing a very small early-stage breast tumor (cryoablation) can be as effective as surgery. It may be an option for people whose tumor is small enough and hasn't spread to lymph nodes or elsewhere.
São Paulo, São PauloAges 18 years+ - NCT03175224RecruitingPhase 2
Test drug APL-101 for lung or other tumors with MET changes
This Phase 2 study tests APL-101 to shrink advanced cancers that have certain MET-related changes, including specific MET mutations, MET gene amplification, or MET fusions. It may help people whose tumors have run out of standard treatment options.
Los Angeles, CaliforniaAges 18 years+ - NCT06900595RecruitingPhase 2
Cabozantinib with immunotherapy for advanced adrenal cancer
This trial tests adding the targeted drug cabozantinib to the immunotherapy cemiplimab for people with advanced adrenocortical carcinoma that cannot be removed by surgery or has spread. It checks if the combination works better than cabozantinib alone.
Phoenix, ArizonaAges 12 years+ - NCT06898684Recruiting
Video exercise program for medulloblastoma survivors
This study tests if a video-based exercise program can help people who finished medulloblastoma treatment, including radiation to the brain and spine, within the last 3 years. It aims to improve strength and well-being.
MünchenAges 3–18 - NCT06898983RecruitingPhase 2
Romiplostim for low platelets from leukemia treatment
This trial tests a drug called Romiplostim to help raise low platelet counts caused by leukemia treatment. It is for adults with leukemia whose platelets are below 50 and who may benefit from this therapy.
Hefei, AnhuiAges 18–75 - NCT06895031RecruitingPhase 2
JYP0015 for advanced solid tumors with RAS mutations
This trial tests a new drug called JYP0015 for people with advanced solid tumors that have a specific change in the RAS gene. It aims to see if the drug can help when other treatments have stopped working or caused too many side effects.
Beijing, Beijing MunicipalityAges 18–75 - NCT06896916RecruitingPhase 1
Study of etentamig and a CELMoD drug for relapsed multiple myeloma
This trial tests a new combination of two drugs—etentamig given through a vein and a CELMoD pill—for people whose multiple myeloma has come back or stopped responding to treatment. The goal is to see if this combination is safe and helps control the disease.
Beverly Hills, CaliforniaAges 18 years+ - NCT06892379RecruitingPhase 1
Study of HS-20110 for advanced solid tumors
This trial is testing a new drug called HS-20110 for people with advanced solid tumors that have not responded to other treatments. It aims to see if the drug is safe and can shrink tumors.
Tamarac, FloridaAges 18 years+ - NCT06892548RecruitingPhase 1/Phase 2
Combination therapy for advanced lung cancer
This trial tests a new combination of two investigational drugs, BNT324 and BNT327, for people with advanced lung cancer that cannot be removed by surgery. It aims to see if the combination is safe and effective for different types of lung cancer, including non-small cell and small cell lung cancer.
Phoenix, ArizonaAges 18 years+ - NCT05775146RecruitingPhase 2
Radiation to liver metastases after colon cancer treatment
This trial studies giving targeted high-dose radiation (SBRT) to liver metastases from colorectal cancer after initial treatment, with the goal of improving long-term control or cure. It may help people who have a limited number of liver spots that doctors think can be treated safely and effectively.
Edmonton, AlbertaAges 18 years+ - NCT05871996Recruiting
Survey study for people with cancer and palliative or oncology care
This trial is testing a questionnaire about language used in cancer care. You may be able to help by filling out a survey if you are 18+ and receiving palliative care or ongoing anti-cancer treatment.
Dublin, County DublinAges 18 years+ - NCT05351216Recruiting
Sirolimus safety with routine vaccines for a rare blood vessel tumor
This trial studies how the medicine sirolimus affects children’s response to routine vaccines during treatment for kaposiform hemangioendothelioma (KHE). It compares vaccinated KHE patients taking sirolimus with healthy children getting the same vaccines.
Shanghai, Shanghai MunicipalityAges Up to 12 years - NCT05796973RecruitingPhase 3
Exercise and atorvastatin for metastatic cancer outcomes
This trial tests whether a structured exercise program, along with the cholesterol medicine atorvastatin, can improve outcomes in people with metastatic prostate, breast, ovarian, or kidney cancer. It may help by reducing inflammation and supporting physical function during cancer treatment.
Tampere, Länsi-SuomiAges 18–99 - NCT06240728RecruitingPhase 1
Testing NPX887 for advanced solid tumors with B7-H7 protein
This trial tests a new drug called NPX887 that targets a protein (B7-H7) on certain cancer cells to help your immune system fight them. It is for people with advanced solid tumors that have not responded to other treatments.
Baltimore, MarylandAges 18 years+ - NCT05863208Recruiting
AI helps doctors see better during colonoscopy
This study tests whether an AI system can improve how doctors detect and evaluate findings during outpatient colonoscopies. You may be eligible if you are having a scheduled sedated colonoscopy and do not have certain bowel conditions or bleeding risks.
Kaohsiung CityAges 40 years+ - NCT06817174Recruiting
CT scan analysis for ovarian cancer treatment planning
This study uses advanced computer analysis of CT scans to help doctors plan the best treatment for advanced ovarian cancer. It is designed for patients who are about to start active treatment, such as surgery or chemotherapy.
LondonAges 18 years+ - NCT06570642Recruiting
Study on emotions and physical activity
This study looks at how emotions affect your desire to be active. You'll wear a Fitbit smartwatch and answer short surveys to help researchers understand what helps people start and stick with physical activity.
Los Angeles, CaliforniaAges 18 years+ - NCT06897046RecruitingPhase 2
Study of Iparomlimab and Tuvonralimab for resectable lung cancer
This trial tests two immunotherapy drugs (iparomlimab and tuvonralimab) before and after surgery for people with a certain type of lung cancer that can be removed. It aims to see if this treatment helps improve outcomes.
BeijingAges 18 years+ - NCT06893276Recruiting
Wellness program for pancreatic cancer
This study tests an online wellness program that helps people with pancreatic cancer manage stress and symptoms. The program is available in English and Spanish and is designed to improve your quality of life during treatment.
Miami, FloridaAges 18 years+
Common questions
- How many cancer clinical trials are recruiting?
- Clin2 is tracking 20,306 recruiting oncology studies from the U.S. registry right now, out of 31,256 we cover in this area in total.
- What does “Cancer” cover here?
- Studies of cancers and tumors of every type and site, from prevention to treatment. We group each study into cancer based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a cancer trial near me?
- Use the search to filter cancer studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Kidney & urinary
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.